Related Experiment Video
Updated: May 23, 2026
06:54
Quantifying Spontaneous Ca2+ Fluxes and their Downstream Effects in Primary Mouse Midbrain Neurons
Published on: September 9, 2020
Parkinson's disease: don't mess with calcium
1Laboratory of Neurosciences, National Institute on Aging Intramural Research Program, Baltimore, Maryland 21224, USA. mattsonm@grc.nia.nih.gov
The Journal of Clinical Investigation
|March 27, 2012
Summary
Reduced calcium influx via TRPC1 channels in Parkinson's disease (PD) models triggers endoplasmic reticulum stress, leading to dopaminergic neuron death. This suggests TRPC1 dysfunction contributes to PD pathogenesis.
Area of Science:
- Neuroscience
- Cell Biology
- Molecular Medicine
Background:
- Parkinson's disease (PD) involves progressive loss of dopaminergic neurons.
- Mitochondrial dysfunction, alpha-synuclein aggregation, and ER stress are implicated in PD pathogenesis.
- The precise sequence of events leading to neurodegeneration remains incompletely understood.
Purpose of the Study:
- To investigate the role of calcium influx through TRPC1 channels in a mouse model of PD.
- To determine if TRPC1 channel activity influences endoplasmic reticulum (ER) stress responses in dopaminergic neurons.
Main Methods:
- Utilized a neurotoxin-based mouse model mimicking Parkinson's disease.
- Measured calcium (Ca2+) influx through transient receptor potential C1 (TRPC1) channels.
- Assessed ER stress markers and dopaminergic neuron viability.
Main Results:
- Reduced Ca2+ influx via TRPC1 channels was observed in dopaminergic neurons.
- This reduction in TRPC1-mediated Ca2+ influx triggered a cell death-inducing ER stress response.
- TRPC1 channels appear crucial for signaling pathways that protect neurons.
Conclusions:
- TRPC1 channels are critical for maintaining calcium homeostasis in dopaminergic neurons.
- Dysfunctional TRPC1-mediated signaling contributes to ER stress and neurodegeneration in PD.
- Targeting TRPC1 channels may offer therapeutic strategies for Parkinson's disease.
Related Concept Videos
01:24Parkinson's Disease: Treatment
Neurodegenerative disorders, such as Parkinson's Disease (PD), involve the gradual and irreversible destruction of neurons in particular brain areas. These disorders exhibit standard features like proteinopathies, selective vulnerability of some neurons, and an interaction of intrinsic properties, genetics, and environmental influences in neural injury.
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
Parkinson's Disease is primarily a result of the loss of dopaminergic neurons in the substantia nigra pars compacta. The cornerstone of its...
01:24Parkinson Disease l: Introduction
Parkinson’s disease is a chronic, progressive neurodegenerative disorder that primarily affects movement. It is characterized by motor symptoms such as resting tremors, muscle rigidity, bradykinesia (slowness of movement), and postural instability. Patients may notice hand tremors at rest, stiffness during movement, or a shuffling gait. In addition to motor features, non-motor symptoms include sleep disturbances, mood and behavioral changes, constipation, and cognitive impairment, all of which...
01:24Parkinson Disease ll: Pathophysiology
Parkinson disease (PD) is a progressive neurodegenerative disorder primarily affecting movement, with additional non-motor features. Its pathophysiology involves complex interactions among genetic susceptibility, environmental exposures, and cellular dysfunction, including dopaminergic neuron loss, protein aggregation, and mitochondrial impairment.Selective NeurodegenerationA key feature is the degeneration of dopaminergic neurons in the substantia nigra pars compacta, leading to reduced...
01:15Parkinson's Disease: Overview
Neurodegenerative disorders are progressive diseases that cause irreversible damage and loss to neurons in specific brain areas. Examples of these disorders include Parkinson's disease, Alzheimer's disease, Multiple Sclerosis (MS), and Amyotrophic Lateral Sclerosis (ALS). These disorders share characteristics such as proteinopathies, selective neuronal vulnerability, and a complex interplay between genetic and environmental factors. The primary therapeutic goal for these conditions is to...
01:21Skeleton and Calcium Homeostasis
Calcium is not only the most abundant mineral in bone but also the most abundant mineral in the human body. Calcium ions are needed for bone mineralization, tooth health, heart rate regulation and strength of contraction, blood coagulation, the contraction of smooth and skeletal muscle cells, and the regulation of nerve impulse conduction. The average calcium level in the blood is about 10 mg/dL. When the body cannot maintain this level, a person will experience hypo or hypercalcemia.
01:17Antiepileptic Drugs: Calcium Channel Blockers
Calcium channel blockers, a class of antiepileptic drugs, regulate the flow of calcium ions within neurons.
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...
Calcium channel blockers exert their antiepileptic effects by targeting T-type calcium channels, which are integral to transmitting nerve signals in the central nervous system. These channels allow the passage of calcium ions, which are vital for neuronal communication. By inhibiting T-type calcium channels, calcium channel blockers effectively reduce the release of neurotransmitters and...